drugset / Trial / NCT00569101

A Pilot Study for the Efficacy and Safety of Tacrolimus in the Treatment of Refractory Lupus Nephritis

NCT00569101

Phase 2 Unknown 9 enrolled Seoul National University Hospital
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this protocol is to determine whether Tacrolimus and Prednisolone are effective and safe in the treatment of the cyclophosphamide-resistant, refractory diffuse proliferative lupus nephritis

Timeline

Start
2007-09
Primary completion
Completion
2008-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Tacrolimus Small molecule 0.02 mg/kg Oral

Indications